We estimate that the CEO and Co-Founder of Hinge Health, Inc. ($HNGE), Daniel Perez, received a compensation of $45,812,139 in 2025. This is an increase of 98.89% from an estimated $508,728 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on April 17, 2026. Note that parsing errors may occur.
You can track $HNGE on Quiver Quantitative's $HNGE stock dashboard.
$HNGE Stock Insider Trading Activity
$HNGE Stock insiders have traded $HNGE stock on the open market 46 times in the past 6 months. Of those trades, 0 have been purchases and 46 have been sales.
Here’s a breakdown of recent trading of $HNGE stock by insiders over the last 6 months:
- HOLDINGS GROUP, LLC INSIGHT has made 0 purchases and 4 sales selling 1,654,440 shares for an estimated $79,016,054.
- VENTURE PARTNERS X L.P. BESSEMER sold 725,000 shares for an estimated $29,036,249
- DANIEL ANTONIO PEREZ (CEO & Co-Founder) has made 0 purchases and 5 sales selling 500,000 shares for an estimated $22,529,443.
- GABRIEL M.I. MECKLENBURG has made 0 purchases and 4 sales selling 216,666 shares for an estimated $9,475,425.
- JAMES BUDGE (Chief Financial Officer) has made 0 purchases and 11 sales selling 81,630 shares for an estimated $3,705,464.
- JAMES PURSLEY (President) has made 0 purchases and 10 sales selling 60,000 shares for an estimated $2,633,348.
- KRISTINA M LESLIE has made 0 purchases and 3 sales selling 7,250 shares for an estimated $311,840.
- ELLIOTT ROBINSON has made 0 purchases and 8 sales selling 0 shares for an estimated $0.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$HNGE Stock Hedge Fund Activity
We have seen 130 institutional investors add shares of $HNGE Stock stock to their portfolio, and 55 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- COATUE MANAGEMENT LLC removed 4,702,208 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $218,417,561
- INSIGHT HOLDINGS GROUP, LLC removed 1,654,440 shares (-15.0%) from their portfolio in Q4 2025, for an estimated $76,848,738
- JANE STREET GROUP, LLC added 1,521,669 shares (+3370.8%) to their portfolio in Q4 2025, for an estimated $70,681,525
- BIT CAPITAL GMBH added 1,466,577 shares (+79.3%) to their portfolio in Q4 2025, for an estimated $68,122,501
- VANGUARD GROUP INC added 1,367,693 shares (+110.5%) to their portfolio in Q4 2025, for an estimated $63,529,339
- TIGER GLOBAL MANAGEMENT LLC added 1,253,743 shares (+227.1%) to their portfolio in Q4 2025, for an estimated $58,236,362
- MARSHALL WACE, LLP added 1,172,631 shares (+inf%) to their portfolio in Q4 2025, for an estimated $54,468,709
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$HNGE Stock Analyst Ratings
Wall Street analysts have issued reports on $HNGE in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 02/11/2026
- Canaccord Genuity issued a "Buy" rating on 02/11/2026
- Barclays issued a "Overweight" rating on 01/05/2026
To track analyst ratings and price targets for $HNGE Stock, check out Quiver Quantitative's $HNGE forecast page.
$HNGE Stock Price Targets
Multiple analysts have issued price targets for $HNGE recently. We have seen 10 analysts offer price targets for $HNGE in the last 6 months, with a median target of $59.0.
Here are some recent targets:
- Elizabeth Anderson from Evercore ISI Group set a target price of $45.0 on 04/08/2026
- Rishi Jaluria from RBC Capital set a target price of $55.0 on 03/11/2026
- Ryan MacDonald from Needham set a target price of $59.0 on 02/11/2026
- Saket Kalia from Barclays set a target price of $52.0 on 02/11/2026
- Aaron Kimson from Citizens set a target price of $65.0 on 02/11/2026
- Richard Close from Canaccord Genuity set a target price of $53.0 on 02/11/2026
- Gene Mannheimer from Freedom Capital Markets set a target price of $59.0 on 01/23/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
